CD8+CD103+PD1+TIM3+ T cells in glioblastoma microenvironment correlate with prognosis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD8+CD103+PD1+TIM3+ T cells in glioblastoma microenvironment correlate with prognosis
Authors
Keywords
-
Journal
IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-27
DOI
10.1111/imm.13710
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD103+CD8+ tissue-resident memory T cell infiltration predicts clinical outcome and adjuvant therapeutic benefit in muscle-invasive bladder cancer
- (2022) Kaifeng Jin et al. BRITISH JOURNAL OF CANCER
- Presence of Tim3 + and PD ‐1 + CD8 + T cells identifies microsatellite stable colorectal carcinomas with immune exhaustion and distinct clinicopathological features
- (2022) Max Klapholz et al. JOURNAL OF PATHOLOGY
- Newly Diagnosed Glioblastoma in Elderly Patients
- (2022) Carlen A. Yuen et al. Current Oncology Reports
- PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes
- (2022) Joji Nagasaki et al. Cell Reports
- Prognostic and Predictive Factors in Elderly Patients With Glioblastoma: A Single-Center Retrospective Study
- (2022) Jinghui Liu et al. Frontiers in Aging Neuroscience
- Emerging therapies for glioblastoma: current state and future directions
- (2022) Liang Rong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CD103+ Tissue Resident T-Lymphocytes Accumulate in Lung Metastases and Are Correlated with Poor Prognosis in ccRCC
- (2022) Christine Sanders et al. Cancers
- The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancer
- (2022) Yohei Nose et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy
- (2022) Adrienne M. Luoma et al. CELL
- Advances in immunotherapy for glioblastoma multiforme
- (2022) Ahmad Bakur Mahmoud et al. Frontiers in Immunology
- Cancer cell intrinsic TIM-3 induces glioblastoma progression
- (2022) Qing Guo et al. iScience
- Age-associated remodeling of T cell immunity and metabolism
- (2022) SeongJun Han et al. Cell Metabolism
- Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma
- (2022) Linda M. Liau et al. JAMA Oncology
- Frontiers in the treatment of glioblastoma: Past, present and emerging
- (2021) Taskeen Iqbal Janjua et al. ADVANCED DRUG DELIVERY REVIEWS
- CD8+CD103+ tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma
- (2021) Chester Lai et al. Journal for ImmunoTherapy of Cancer
- Proteogenomic and metabolomic characterization of human glioblastoma
- (2021) Liang-Bo Wang et al. CANCER CELL
- Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
- (2021) Riyao Yang et al. Nature Communications
- Tissue-resident memory T cells in tumor immunity and immunotherapy
- (2021) Karolina Okła et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Discrete tissue microenvironments instruct diversity in resident memory T cell function and plasticity
- (2021) Susan N. Christo et al. NATURE IMMUNOLOGY
- Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?
- (2021) Aurelia Santoro et al. AGEING RESEARCH REVIEWS
- Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement
- (2021) Stephen J. Bagley et al. CLINICAL CANCER RESEARCH
- Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions
- (2020) Nina L Fransen et al. BRAIN
- Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
- (2020) Florian Klemm et al. CELL
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
- (2020) David A. Reardon et al. JAMA Oncology
- Immune suppression in gliomas
- (2020) Matthew M. Grabowski et al. JOURNAL OF NEURO-ONCOLOGY
- CD103+ tumor-resident CD8+ T cell numbers underlie improved patient survival in oropharyngeal squamous cell carcinoma
- (2020) Rehana Hewavisenti et al. Journal for ImmunoTherapy of Cancer
- The tumor microenvironment: Prognostic and theranostic impact. Recent advances and trends
- (2020) Wolf H. Fridman SEMINARS IN IMMUNOLOGY
- Brain Tumor Microenvironment and Host State: Implications for Immunotherapy
- (2019) William Tomaszewski et al. CLINICAL CANCER RESEARCH
- Tissue-resident memory T cells at the center of immunity to solid tumors
- (2018) Derk Amsen et al. NATURE IMMUNOLOGY
- Resident memory T cells, critical components in tumor immunology
- (2018) Fathia Mami-Chouaib et al. Journal for ImmunoTherapy of Cancer
- Tissue-resident memory T cells populate the human brain
- (2018) Joost Smolders et al. Nature Communications
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now